HNGE Hinge Health, Inc.
Company Analysis
Latest News
🔴 Hinge Health is trading 4.14% down today with no clear company-specific catalyst
Hinge Health is trading 4.14% down at $89.01 after no clear company-specific catalyst emerged in available August 28, 2026 coverage. - Recent company news...
🟢 Hinge Health is trading 5.6% up today as Nasdaq gains 1.04%
Hinge Health is trading at $95.53, up 5.56%, alongside a risk-on technology market, with the Nasdaq Composite up 1.04%. - Search results found no fresh August...
Hinge Health Signs $86 Million Lease for New San Francisco Office Space
Hinge Health, Inc. has entered into a material lease agreement for approximately 119,278 square feet of office space at 300 Mission Street in San Francisco....
🟢 Hinge Health shares surge 4.3% after Truist raises target to $112 on strong Q2 results and Cylinder Health acquisition
Hinge Health is trading at $95.50, up 4.31% in after-hours trading following several positive developments: * Truist raised its price target to $112 from...
Hinge Health Triples Down on Growth With a Blowout Quarter and a Gut-Health Bet — But Can the Stock Keep Pace With the Ambition?
Shares of Hinge Health surged 11.9% to $88.90 after the digital healthcare company delivered a second quarter that handily beat expectations, hiked its annual...
🟢 Hinge Health is trading 11% up today after earnings beat and raised 2026 guidance
Hinge Health is trading 11.16% up at $89.02 as investors respond to its August 4 earnings beat, raised 2026 revenue guidance, and planned $105 million Cylinder...
🟢 Hinge Health is trading 11.9% up today after strong Q2 results and GI acquisition
Hinge Health is trading 11.9% up at $88.90 after reporting strong second-quarter 2026 results and raising its full-year guidance. • The company posted...
🟢 Hinge Health is trading 5.6% up today after Q2 earnings beat and $105M Cylinder Health acquisition
Hinge Health is trading at $83.85 (5.6% up) after posting a major second-quarter earnings beat and raising its full-year 2026 revenue guidance. • The company...
🔴 Hinge Health is trading 4.3% down today in a post-earnings reversal despite raised guidance
Hinge Health is trading 4.3% down at $76.03 following a post-earnings reversal, despite reporting strong Q2 results and raising its full-year guidance. • The...
Hinge Health's second quarter revenue grew 53% to beat estimates, leading to raised FY2026 guidance and an acquisition.
Hinge Health reported second quarter 2026 revenue of $212.8 million, up 53% year-over-year, and GAAP EPS of $0.52, beating analyst estimates. The company also...
🟢 Hinge Health is trading 4.2% up today ahead of Q2 earnings and a broader risk-on rally
Hinge Health is trading 4.2% up at $80.91 as investors position ahead of its Q2 2026 earnings report and a broader risk-on market rally. • The company is...
🟢 Hinge Health is trading 4.6% up today ahead of Q2 earnings and broader market gains
Hinge Health is trading 4.6% up at $78.11 as investors position ahead of its Q2 2026 earnings report scheduled for August 4, 2026. • Analysts expect the...
Hinge Health, Inc. Q2 2026 Earnings Preview: What Analysts Expect on August 04, 2026
Hinge Health, Inc. (HNGE) is projected to report Q2 2026 revenue of $201.1 million and EPS of $0.28, with shares currently trading near $74.71 compared to an...
🔴 Hinge Health is trading 4.1% down today amid profit-taking after a sharp multi-week rally
Hinge Health is trading at $72.02 (4.1% down) as the stock undergoes short-term consolidation and profit-taking following a sharp multi-week run. • The recent...
🔴 Hinge Health is trading 5.6% down
Hinge Health is trading at $79.66, down 5.6% from a comparison close of $84.35 during regular trading. This is a price-action follow-up, so a separate catalyst...
🔴 Hinge Health is trading 4.03% down today despite broader market gains
Hinge Health is trading 4.03% down at $84.17 following a quiet session with no clearly identified company-specific catalyst. • The decline appears...
Hinge Health target raised to $108, Morgan Stanley cites improved growth outlook
Morgan Stanley raised its price target for Hinge Health (NYSE:HNGE) to $108 from $72. This adjustment represents a 50% increase while the bank maintains an...
Hinge Health Shareholder Insight Holdings Sells $38M Stake After Stock Conversion
Insight Holdings Group, LLC entities sold 426,171 shares of Hinge Health, Inc. Class A Common Stock on July 7 and July 9, 2026. The total transaction value...
🟢 HNGE is trading 4.1% up today as raised 2026 guidance and Russell index inclusion extend rally
HNGE is trading 4.1% up now at $86.42 as investors continue to react to Hinge Health’s recently raised second-quarter and full-year 2026 guidance. • Momentum...
Hinge Health Joins Russell Indexes, Boosting Investor Visibility and Liquidity
Hinge Health, Inc. will join the Russell 3000E and Russell 2000 Growth Indexes on June 29, 2026. The inclusion occurs as part of the annual Russell U.S....